Han Biomedical

Han Biomedical EBIT per Share

The EBIT per Share of Han Biomedical (6999.TWO) as of Oct 10, 2026 is 1.28 TWD. In the previous year, EBIT per Share was 1.16 TWD — a change of 10.85% (higher).

EBIT per Share

1.28TWD

YoY

10.85%

Last updated:

EBIT per Share of Han Biomedical is 2024 1.28 TWD. EBIT per Share of Han Biomedical was 2023 1.16 TWD. It decreases by 10.85% higher compared to the previous year.

The Han Biomedical EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
1.08 TWD
Jan 1, 2023
1.16 TWD
Jan 1, 2024
1.28 TWD
The Han Biomedical EBIT per Share history
YEAREBIT per ShareYoY
1.28TWD+10.85%
1.16TWD+6.95%
1.08TWD—
Access this data via the Eulerpool API
Get Free API Key

Han Biomedical Stock analysis

What does Han Biomedical do? Han Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Han Biomedical stock

EBIT per Share of Han Biomedical is 1.28 TWD in 2024.

EBIT per Share of Han Biomedical changed from 1.16 TWD to 1.28 TWD, representing a 10.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Han Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Han Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Han Biomedical